Health Condition of Cannabis Consumers in the Canadian Population

Cannabis Use Clinical Trial

Official title:

Health Condition of Cannabis Consumers in the Canadian Population: A Population-based Observational Cohort Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03987347
• Other study ID #: 2020-1830
• Status: Withdrawn
• Start date: December 1, 2020
• Est. completion date: December 1, 2020

Study information

• Verified date: December 2020
• Source: Jewish General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the health condition and its evolution with time of Cannabis consumers in the Canadian population.

Description:

In Canada, legalization of recreational use is likely to have decreased the perception of risks associated with Cannabis use, and means that the reported adverse effects of Cannabis are not so important, suggesting that Cannabis may be useful for their illness as an alternative or complementary therapeutic.

More Canadian physicians prescribed Cannabis for their patients. Both Recreational and medical use of Cannabis increase and will continue to grow up in the next coming years. Regardless, the typology of Cannabis use, more information on the health condition of Cannabis consumers may be helpful for the medical prescription of Cannabis, in particular in older adults who are more at risk of side effects.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 1, 2020
• Est. primary completion date: December 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Living in Canada the last 20 years

• Being 60 years and over

• Being consumer of cannabis

Exclusion Criteria:

• Living outside Canada the last 20 years

• Have never consumed cannabis

Related Conditions & MeSH terms

• Cannabis Use
• Health Risk
• Marijuana Abuse
• Old Age

Intervention

Other:
• Observational
People who are enrolled in the Canadian Longitudinal Study on Aging. Participants undergo repeated waves of the same standardized data collection every three years. All participants are also contacted by telephone 18 months after baseline assessment to complete the Maintaining Contact Questionnaire.

Locations

Country	Name	City	State
Canada	Jewish General Hospital	Montréal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Jewish General Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Neurocognitive disorder	The decrease of cognitive function changes the activities of daily living to older adults. Instrumental Activities of Daily Living Scale ( IADLs) will be used to assess independent living skills to people who are a diagnosis of mild cognitive impairment. A summary score range from 0 ( low function, dependent) to 8 ( high function, independent) will be given to each participant based on their daily activities.	around 20 years
Secondary	Depression	It will be used the Centre for Epidemiologic Studies-Depression Scale (CES-D) that rates how often over the past week people experience symptoms that are associated with depression. In scoring the Center for Epidemiologic Studies Depression Scale, a value of 0,1,2,3 is assigned to a response based on the emotional feelings that the participants have.	around 20 years